tickdelta
tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

INCYIncyte

Health care · Research Services · Nasdaq

Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. 10-K, Item 1

INCY quote by TradingView
Employees
2,844
Headquarters
Wilmington, DE
CEO
William Meury
Next results
around Feb 9, 2027
Compare with peers → Embed

Every trade in INCY shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.

Bought on the market $0 0 trades by 0 insiders
Sold on the market $20.5M 27 trades by 6 insiders
AllBuys and salesBuysSales
DateInsiderRoleTypeSharesPriceValueOwned after
Nov 3, 2026 Thomas TrayPrincipal Accounting Officer Sale (10b5-1) -610 118.96 73K 21,126
Oct 15, 2026 Pablo J. CagnoniPresident, Global Head of R&D Sale (10b5-1) -2,642 112.71 298K 183,200
Sep 15, 2026 Pablo J. CagnoniPresident, Global Head of R&D Sale (10b5-1) -9,233 120.50 1.1M 197,185
Sep 15, 2026 Pablo J. CagnoniPresident, Global Head of R&D Sale (10b5-1) -13,985 120.49 1.7M 183,200
Aug 19, 2026 Pablo J. CagnoniPresident, Global Head of R&D Sale (10b5-1) -10,801 125.56 1.4M 183,200
Aug 12, 2026 Pablo J. CagnoniPresident, Global Head of R&D Sale (10b5-1) -10,803 120.04 1.3M 194,001
Aug 5, 2026 Pablo J. CagnoniPresident, Global Head of R&D Sale (10b5-1) -10,640 122.69 1.3M 204,804
Aug 5, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -2,207 123.99 274K 61,441
Aug 3, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -6,055 120.43 729K 61,441
Jul 31, 2026 Pablo J. CagnoniPresident, Global Head of R&D Sale (10b5-1) -15,888 119.70 1.9M 215,444
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -14,661 119.46 1.8M 88,679
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -5,332 119.42 637K 83,347
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -2,187 119.47 261K 81,160
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -6,171 119.43 737K 74,989
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -4,695 119.39 561K 70,294
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -2,864 119.40 342K 67,430
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -1,643 119.51 196K 65,787
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -1,642 119.38 196K 64,145
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -85 122.19 10K 64,060
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -326 121.69 40K 63,734
Jul 31, 2026 Patrick A. MayesEVP & Chief Scientific Officer Sale (10b5-1) -2,293 119.41 274K 61,441
Jul 16, 2026 Steven H. SteinCMO & Head of Late-Stage Dev. Sale (10b5-1) -1,877 114.73 215K 21,118
Jul 16, 2026 Mohamed Khairie IssaEVP, Head of U.S. Commercial Sale (10b5-1) -1,093 115.01 126K 63,940
Jul 15, 2026 Steven H. SteinCMO & Head of Late-Stage Dev. Sale (10b5-1) -28,237 113.05 3.2M 26,083
Jun 4, 2026 Thomas TrayPrincipal Accounting Officer Sale (10b5-1) -2,639 100.00 264K 21,132
May 26, 2026 Thomas TrayPrincipal Accounting Officer Sale (10b5-1) -2,051 97.35 200K 21,132
May 19, 2026 Paul J. ClancyDirector Sale (10b5-1) -15,000 94.93 1.4M 23,741

From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).

Work on INCY in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/INCY/export.csv") into a cell.